Loviride
Loviride (R 89439) is a non-nucleoside reverse transcriptase inhibitor (NNRTI), with an IC50 of 0.3 μM for reverse transcriptase from HIV-1. Loviride (R 89439) inhibits HIV-1, HIV-2 and SIV replication in MT-4 cells[1].
Product Specifications
CAS Number
[147362-57-0]
Product Name Alternative
R 89439
UNSPSC
12352005
Target
HIV; Reverse Transcriptase
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Loviride.html
Purity
99.59
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(N)C(NC1=C(C(C)=O)C=CC(C)=C1)C2=C(Cl)C=CC=C2Cl
Molecular Formula
C17H16Cl2N2O2
Molecular Weight
351.23
References & Citations
[1]Witvrouw M, et al. Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV. AIDS. 1999 Aug 20;13 (12) :1477-83.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
HIV-1; HIV-2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral mouse Trpm7 shRNA (UAS) - Lentiviral mouse Trpm7 shRNA (UAS, RFP) (25)
ATP6V0A4, ID (ATP6V0A4, ATP6N1B, ATP6N2, V-type proton ATPase 116kD subunit a isoform 4, Vacuolar proton translocating ATPase 116kD subunit a isoform 4, Vacuolar proton translocating ATPase 116kD subunit a kidney isoform) (MaxLight 550)
ATP6V0A4, ID (ATP6V0A4, ATP6N1B, ATP6N2, V-type proton ATPase 116kD subunit a isoform 4, Vacuolar proton translocating ATPase 116kD subunit a isoform 4, Vacuolar proton translocating ATPase 116kD subunit a kidney isoform) (MaxLight 550)